August 08, 2025 A new era of personalized neuromodulation UCI Health offers adaptive deep brain stimulation for Parkinson’s disease. UCI Health
August 05, 2025 Polatuzumab Vedotin–Based Regimen Improves Overall Survival in Refractory DLBCL The ASCO Post
June 19, 2025 Ropeginterferon Alfa-2b Outperforms Anagrelide as Second-Line Therapy for ET, Study Finds The ASCO Post
July 08, 2025 Lenz Therapeutics Announces FDA Approval of Vizz for the Treatment of Presbyopia Ophthalmic Professional